RondinX Overview

  • Founded
  • 2015
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

RondinX General Information

Description

Provider of a drug discovery platform in the field of microbiome therapeutics and companion diagnostics. The company develops PTR (Peak-to-Trough) family of algorithms, which is a cloud based, computational pipeline used to derive both static and dynamic strain level insights into the bacterial ecosystem.

Contact Information

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare
Acquirer
Primary Office
  • Tel Aviv
  • Israel
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RondinX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 19-Dec-2017 00.00 Completed Startup
1. Seed Round 01-Mar-2016 00.00 00.00 Completed Startup
To view RondinX’s complete valuation and funding history, request access »

RondinX Executive Team (4)

Name Title Board Seat Contact Info
Elad Kehat Chief Technology Officer
Alon Hirsch Co-Founder, Chief Financial Officer & Chief Operating Officer
Rafi Gidron Ph.D Co-Founder & Chairman
To view RondinX’s complete executive team members history, request access »

RondinX Board Members (1)

Name Representing Role Since
Rafi Gidron Ph.D Self Co-Founder & Chairman 000 0000
To view RondinX’s complete board members history, request access »

RondinX Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
8VC Venture Capital Minority 000 0000 000000 0
Baruch Future Ventures Venture Capital Minority 000 0000 000000 0
Elevator Fund Venture Capital Minority 000 0000 000000 0
To view RondinX’s complete investors history, request access »